Treace Medical Concepts, Inc.
TMCI
$1.24
-$0.07-5.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -59.00M | -50.11M | -49.18M | -52.99M | -55.74M |
| Total Depreciation and Amortization | 9.62M | 9.05M | 8.43M | 7.97M | 7.42M |
| Total Amortization of Deferred Charges | 1.29M | 1.30M | 1.30M | 1.30M | 1.30M |
| Total Other Non-Cash Items | 40.70M | 40.09M | 38.37M | 37.26M | 35.29M |
| Change in Net Operating Assets | -8.58M | -12.49M | -13.82M | -19.29M | -25.43M |
| Cash from Operations | -15.97M | -12.15M | -14.90M | -25.75M | -37.17M |
| Capital Expenditure | -13.52M | -14.19M | -14.25M | -11.21M | -11.59M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.77M | 21.20M | 18.28M | 40.93M | 46.97M |
| Cash from Investing | 13.25M | 7.01M | 4.03M | 29.72M | 35.38M |
| Total Debt Issued | 60.86M | 1.55M | 983.00K | -- | -- |
| Total Debt Repaid | -57.23M | -507.00K | -98.00K | -- | -- |
| Issuance of Common Stock | 546.00K | 533.00K | 300.00K | 495.00K | 428.00K |
| Repurchase of Common Stock | -902.00K | -858.00K | -446.00K | -432.00K | -268.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.20M | -- | -- | -- | -- |
| Cash from Financing | 2.08M | 721.00K | 739.00K | 63.00K | 160.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -642.00K | -4.42M | -10.13M | 4.04M | -1.63M |